Novel mTOR Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeting Agents.
Ying-Qi FengBo-An LiFan FengYong-Shou ChenYi-Xin RenHeng ZhangShuang CaoPublished in: OncoTargets and therapy (2020)
Our study identified a new type of small-molecular inhibitors of mTOR and confirmed their ability to enhance the antitumor effect of molecular-targeted agents on advanced HCC.